Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP140967.RAo6VA9tTaIyH2c744WCEj5DyIFpmvK8CjWa2FhG6S5H4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP140967.RAo6VA9tTaIyH2c744WCEj5DyIFpmvK8CjWa2FhG6S5H4130_assertion type Assertion NP140967.RAo6VA9tTaIyH2c744WCEj5DyIFpmvK8CjWa2FhG6S5H4130_head.
- NP140967.RAo6VA9tTaIyH2c744WCEj5DyIFpmvK8CjWa2FhG6S5H4130_assertion description "[NOD2 polymorphism screening should be used to optimize donor selection and antimicrobial prophylaxis to reduce the occurrence of aGVHD and TRM following allogeneic HSCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP140967.RAo6VA9tTaIyH2c744WCEj5DyIFpmvK8CjWa2FhG6S5H4130_provenance.
- NP140967.RAo6VA9tTaIyH2c744WCEj5DyIFpmvK8CjWa2FhG6S5H4130_assertion evidence source_evidence_literature NP140967.RAo6VA9tTaIyH2c744WCEj5DyIFpmvK8CjWa2FhG6S5H4130_provenance.
- NP140967.RAo6VA9tTaIyH2c744WCEj5DyIFpmvK8CjWa2FhG6S5H4130_assertion SIO_000772 19219079 NP140967.RAo6VA9tTaIyH2c744WCEj5DyIFpmvK8CjWa2FhG6S5H4130_provenance.
- NP140967.RAo6VA9tTaIyH2c744WCEj5DyIFpmvK8CjWa2FhG6S5H4130_assertion wasDerivedFrom gad-20150221 NP140967.RAo6VA9tTaIyH2c744WCEj5DyIFpmvK8CjWa2FhG6S5H4130_provenance.
- NP140967.RAo6VA9tTaIyH2c744WCEj5DyIFpmvK8CjWa2FhG6S5H4130_assertion wasGeneratedBy ECO_0000203 NP140967.RAo6VA9tTaIyH2c744WCEj5DyIFpmvK8CjWa2FhG6S5H4130_provenance.